Friday, November 30, 2012 3:18:11 PM
Here's how I see it:
Initial investment of $2M @ .186 = 10,792,688 shares.
At a later date, set by the SEC, APDN will receive an additional $5.5M and the investor will receive additional shares up to a maximum of 9.9% O/S. If the price of the shares are .157 at the time, the investor will receive an additional 35M shares. If the share price is at or over .186 at the time, the investor will receive an additional 29,569,892 shares.
With the warrants, they could purchase an additional xxM shares at a fixed price of .2232 regardless of what the share price is at the time. Total dilution would end up at roughly 70M shares.
Anyone see it differently?
Initial investment of $2M @ .186 = 10,792,688 shares.
At a later date, set by the SEC, APDN will receive an additional $5.5M and the investor will receive additional shares up to a maximum of 9.9% O/S. If the price of the shares are .157 at the time, the investor will receive an additional 35M shares. If the share price is at or over .186 at the time, the investor will receive an additional 29,569,892 shares.
With the warrants, they could purchase an additional xxM shares at a fixed price of .2232 regardless of what the share price is at the time. Total dilution would end up at roughly 70M shares.
Anyone see it differently?
Recent BNBX News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/27/2026 12:15:32 PM
- BNB Plus Corp. (BNBX) Secures Initial Commitments for $4.1M in Strategic Financing • Business Wire • 05/26/2026 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 08:21:22 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 12:30:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 08:10:24 PM
- BNB Plus Corp. Completes Historic $1.2 Million LineaDNA™ Order • Business Wire • 04/23/2026 11:00:00 AM
- BNB Plus Corp. Announces Review of Strategic Alternatives to Maximize Shareholder Value • Business Wire • 04/20/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:09:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:08:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:07:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:06:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:06:14 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/24/2026 08:15:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 08:06:00 PM
- BNB Plus Corp. Announces European Patent Grant for Fundamental Technology Underlying its Linea™ IVT Platform • Business Wire • 03/18/2026 12:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/12/2026 09:24:23 PM
- BNB Plus Corp. (BNBX) Receives Two New Orders for LineaDNA™ from Genetic Medicine Developers • Business Wire • 02/24/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2026 09:16:58 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/13/2026 07:49:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2026 09:32:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 09:11:07 PM
- BNB Plus Corp. (BNBX) Appoints James Haft as Independent Board Director • Business Wire • 02/05/2026 01:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/30/2026 09:06:16 PM
